Expanding Market Share in Overseas Contact Lens Operations

「In Europe and North America, continued sales activities targeting major mass retailers led to increased orders for daily disposable contact lenses, mainly from existing customers, and expanded sales.」

「Overseas, we will expand transactions with major mass-retail chains and work to increase sales.」

「During the current interim consolidated accounting period, we acquired 100% of the shares of 3 sales companies in Southeast Asia and made them wholly owned subsidiaries in order to secure sales bases for contact lenses and care products in the region.」

「Overseas revenue increased by ¥3,322 million, mainly because sales of disposable contact lenses and care products in Europe and North America remained firm.」

「Overseas revenue increased by ¥2,232 million, mainly because sales of disposable contact lenses and care products in Europe and North America remained firm.」

「Overseas revenue increased by ¥1,883 million, mainly because sales of daily disposable contact lenses and care products in Europe and North America, as well as orthokeratology lenses in China, remained firm.」

「Overseas revenue increased by ¥715 million, mainly due to increased sales of daily disposable contact lenses in Europe and North America.」

「Overall, revenue in the overseas vision care business increased 28.4% year on year, driven by revenue growth from strategic initiatives and the tailwind from the weaker yen. The overseas revenue ratio rose from 22.2% in the previous fiscal year to 25.9% in the current fiscal year.」

「Revenue in the vision care business increased by ¥6,748 million from the same quarter of the previous year. The main factors were recovery from the impact of COVID-19 and steady sales of orthokeratology lenses and care products in China. Overseas revenue increased by ¥5,007 million year on year, while domestic revenue increased by ¥1,741 million.」

「Revenue in the vision care business increased by ¥4,958 million from the same quarter of the previous year. The main factors were recovery from the impact of COVID-19 and steady sales of orthokeratology lenses and care products in China. Overseas revenue increased by ¥3,541 million year on year, while domestic revenue increased by ¥1,417 million.」

「Over the same quarter of the previous year, overseas revenue increased by ¥1,618 million and domestic revenue by ¥779 million.」

「Overall, the overseas vision care business grew strongly, with revenue up 46.9% year on year. The overseas revenue ratio rose significantly to 22.2%, from 17.6% in the previous fiscal year.」

「During the current quarterly consolidated accounting period, we began doing business with a new UK mass retailer. We are also rolling out sales promotions in partnership with mass retailers across Europe, primarily to expand transaction volumes for daily disposable contact lenses.」

「During the current quarterly consolidated accounting period, we began doing business with a new Dutch mass retailer and stepped up efforts to expand transaction volumes.」

「In Europe, vaccination against COVID-19 has progressed and economic activity has been recovering. We are pursuing a policy of developing new relationships with key mass retailers and strengthening existing relationships to expand sales of disposable contact lenses, while also strengthening the foundation of our myopia-control business. During the current quarterly consolidated accounting period, we began doing business with a new German mass retailer and are stepping up efforts to expand transaction volumes.」

「Despite the challenging environment, we were able to expand the business by acquiring new sales outlets, strengthening our sales network through M&A and developing our logistics functions. Overall, the overseas contact lens business grew, with sales increasing 27.9% year on year.」

「In the Chinese market, we entered into a share transfer agreement to make 板橋貿易株式会社 a wholly owned subsidiary, with the aim of strengthening our sales network in the expanding market for orthokeratology lenses and other products.」

「Although our overseas sales activities were affected by worldwide restrictions on movement and business closures to contain COVID-19, we continued sales activities and launched new products while implementing infection prevention measures in that environment.」

「In Asia, we acquired an additional interest in 温州欣視界科技有限公司 in June and made it a wholly owned subsidiary. In recent years, China has seen an increase in both the myopic population and the number of people seeking treatment for irregular corneal astigmatism. We therefore established a manufacturing facility in China to supply rigid and specialty contact lenses to local medical institutions and patients with short lead times. Going forward, with our technical support, we will work to further expand our sales base.」

「In North America, we strengthened promotion of the “Miru 1month Menicon” series to strengthen our disposable contact lens business, and began supplying 1-day disposable contact lenses as private-label products for major retail chains. In November, we obtained U.S. FDA (U.S. Food and Drug Administration) approval for the orthokeratology lens “Menicon Z Night,” taking the lead in addressing the issues associated with the growing myopic population.」

「As regional measures, in North America we worked to expand sales channels and geographic coverage, beginning with stronger promotion of the “Miru 1month Menicon” series, which includes lenses for myopia, hyperopia, astigmatism and presbyopia, in order to strengthen our disposable contact lens business.」

「We will progressively expand the sales regions for this product and work to strengthen our business foundation.」

「We believe that expanding our overseas business and increasing the proportion of sales generated overseas are essential to the group’s further development.」

「Going forward, we will continue working to expand sales of the “Miru” series and raise awareness of the brand.」

「In North America and Europe, we strengthened sales of disposable contact lenses, focusing on private-label products for retail chains, and worked to develop new channels and expand product sales.」

「In our overseas business by region, we are working to further strengthen disposable contact lens sales in Europe and North America by developing new channels and expanding the markets in which our products are sold. At the same time, we are preparing to introduce “1DAY Menicon Premio,” which has already been well received in Japan, sequentially into key markets.」

「By region, in North America and Europe we strengthened sales of disposable contact lenses, developed new channels and worked to expand product sales. In Asia, sales of lens care products for China have been strong, and we are also working to expand our business base in China through sales of orthokeratology lenses.」

「In North America and Europe, we strengthened sales of disposable contact lenses, developed new channels and worked to expand sales of our products. In Asia, we have been working to expand our business base in China through sales of orthokeratology lenses.」

「As it becomes more difficult to acquire new customers in Japan’s contact lens and lens care products markets due to the declining birth rate and aging population, among other factors, we believe that developing overseas markets is important for our group to secure business growth.」

「Going forward, we will continue working to strengthen our overseas business by leveraging our high product quality to supply products suited to each overseas market in a timely manner.」

「Going forward, we will continue working to strengthen our overseas business by leveraging our high product quality to supply products suited to each overseas market in a timely manner.」

「Going forward, we will continue working to expand our overseas market share by leveraging our high product quality and to strengthen the group’s business foundation.」